[摘要] 目的 评价阿立哌唑与利培酮对首发精神分裂症患者认知功能及社会功能的影响。 方法 选择我院2016年7月～2018年6月收治的精神分裂症患者60例为本次研究对象，按照随机数字表法分为对照组30例与观察组30例。对照组给予利培酮治疗，观察组给予阿立哌唑治疗，对比两组患者认知功能及社会功能改善情况。 结果 PANSS情况：治疗前两组患者的PANSS评分比较，差异无统计学意义(P>0.05)，第12周时观察组优于对照组，差异存在统计学意义(P0.05)，第12周时除NAB-Mazes外其余因子观察组优于对照组，差异有统计学意义(P0.05)，第12周时两组患者PSP评分比较，差异无统计学意义(P>0.05);第12周与治疗前比较，两组组内评分均存在统计学意义(P0.05). At 12 weeks， the observation group was superior to the control group， and the difference was statistically significant(P0.05). At the 12th week， the other factors except NAB-Mazes were better in the observation group than in the control group(P0.05). There was no significant difference in PSP score between the two groups at 12 weeks(P>0.05). At week 12， the scores of both groups were statistically different from those before treatment(P, http://www.100md.com(刘会国) 第 1 2 3 4 页 下一页
 百拇医药网 http://www.100md.com/html/paper/1673-9701/2019/14/07.htm